Artificial Pancreas Systems Market Growth, Trends, Industry Analysis and Forecast – 2027

Artificial pancreas is a technology being developed to provide an alternative endocrine function to a healthy pancreas, allowing diabetics to automatically control their blood sugar levels.

In terms of application, type 1 diabetes was the largest downstream consumer of artificial pancreas systems worldwide in 2017, accounting for over 90% share. And revenue in this segment is projected to show a CAGR of 131% from 2017 to 2027.

Artificial Pancreas Systems market was 91 million US$ in 2017 and is expected to 220 million US$ by the end of 2027, growing at a CAGR of 11% between 2021 and 2027.

The key manufacturers in this market include

• Medtronic
• JDRF
• Tandem Diabetes Care
• Pancreum
• TypeZero Technologies
• Beta Bionics
• Johnson & Johnson
• Insulet Corp
• Bigfoot Biomedical
• Dexcom

By the product type, the market is primarily split into

• Control to Range (CTR) System
• Control to Target (CTT) System
• Threshold Suspended Device

Scope of the Report The research study analyzes the global Artificial Pancreas Systems industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as: Recent Developments o Market Overview and growth analysis o Import and Export Overview o Volume Analysis o Current Market Trends and Future Outlook o Market Opportunistic and Attractive Investment Segment Geographic Coverage o North America Market Size and/or Volume o Latin America Market Size and/or Volume o Europe Market Size and/or Volume o Asia-Pacific Market Size and/or Volume o Rest of the world Market Size and/or Volume Key Questions Answered by Artificial Pancreas Systems Market Report 1. What was the Artificial Pancreas Systems Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

What will be the CAGR of Artificial Pancreas Systems Market during the forecast period (2021-2027)? 3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027). 4. Which manufacturer/vendor/players in the Artificial Pancreas Systems Market was the market leader in 2020? 5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Artificial Pancreas Systems market.
• The market share of the global Artificial Pancreas Systems market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Artificial Pancreas Systems market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Artificial Pancreas Systems market.